HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Guideline development for the evaluation of visual impairment in Korea.

Abstract
This guideline is developed to provide criteria for evaluating permanent impairment of the visual system as it affects an individual's ability to perform activities of daily living. This new assessment system is based on the 5th and 6th edition of American Medical Association and McBride impairment assessment system but revised on the consideration of Korean culture and simple application. This evaluation of impairment is based on an assessment of visual acuity and visual field. Especially it weighs binocular vision and binocular visual fields and the binocular vision and binocular visual fields provide 50% of weight and the right and left eye each contribute 25%. A further adjustment of the impairment rating is included at the final step of this evaluation. Functional deficits for individual adjustments include diplopia, problem of accommodation, abnormality of eyelids, tearing, cosmetic problems from cornea opacity, glare, aphakia, and dark-adaptation. The adjustment can be added to impairment rating up to 15%. Further study is necessary to revise and update of this disability evaluation that have potential problems in actual application.
AuthorsHee Seung Chin, Song Hee Park, In Ki Park, Ji Won Kwon, Soo Jeong Lee, Steering Committee of Korean Guides for Impairment Rating in Korean Academy of Medical Sciences
JournalJournal of Korean medical science (J Korean Med Sci) Vol. 24 Suppl 2 Issue Suppl 2 Pg. S252-7 (May 2009) ISSN: 1598-6357 [Electronic] Korea (South)
PMID19503681 (Publication Type: Journal Article, Practice Guideline)
Topics
  • Disability Evaluation
  • Humans
  • Korea
  • Program Development
  • Vision Disorders (classification, diagnosis)
  • Visual Acuity
  • Visual Fields

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: